Released Apr 2, 2025, after the close
10-Q filed May 14, 2025, 44 days after period end · 0001641172-25-010270
Q1 2025 · 10-Q
Revenue—
Net Income-$81.00K-$81.00K N/M vs Q1 2024N/M vs Q4 2024
EPS Diluted$0.00$0.00 N/M vs Q1 2024no prior Q4 2024 on file
Operating Income-$4,214,000N/M
Operating Cash Flow-$3,247,000N/M
What the release said
The release
Same quarter
| Metric | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Revenue | — | $29.00K | $0.00 | $0.00 |
| Net Income | -$81.00K | -$2.95M | -$5.80M | -$4.11M |
| EPS Diluted | $0.00 | -$2.27 | -$7.00 | -$0.42 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio Green Med Solution, Inc. · CIK 1130166 · Engraved from SEC EDGAR